Boston Scientific Corporation (BSX) quarterly balance sheet — complete assets, liabilities & equity history
| Total Current Assets | 8.68B | 8.79B | 8.04B | 7.12B | 7.33B | 6.92B | 8.76B | 8.99B | 8.19B | 6.51B | 6.5B | 5.89B |
| Cash & Short-Term Investments | 1.52B | 2.04B | 1.27B | 534M | 725M | 414M | 2.5B | 2.91B | 2.33B | 865M | 952M | 426M |
| Cash Only | 1.52B | 2.04B | 1.27B | 534M | 725M | 414M | 2.5B | 2.91B | 2.33B | 865M | 952M | 426M |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 3.03B | 2.93B | 2.83B | 2.81B | 2.69B | 2.56B | 2.5B | 2.4B | 2.3B | 2.23B | 2.1B | 2.13B |
| Days Sales Outstanding | 51.49 | 50.07 | 51.25 | 49.52 | 50.67 | 51.02 | 53.56 | 51.95 | 53.48 | 53.46 | 55.23 | 53.22 |
| Inventory | 3.12B | 2.94B | 2.92B | 2.86B | 2.87B | 2.81B | 2.75B | 2.61B | 2.56B | 2.48B | 2.4B | 2.25B |
| Days Inventory Outstanding | 171.54 | 200.14 | 174.64 | 159.21 | 149.13 | 135.4 | 157.98 | 153.22 | 155.94 | 159.13 | 157.41 | 147.88 |
| Other Current Assets | 658M | 580M | 701M | 613M | 756M | 831M | 673M | 755M | 672M | 622M | 740M | 773M |
| Total Non-Current Assets | 35.67B | 34.88B | 34.67B | 34.44B | 32.8B | 32.48B | 29.32B | 28.12B | 28.48B | 28.62B | 27.54B | 27.72B |
| Property, Plant & Equipment | 4.61B | 4.5B | 4.29B | 3.95B | 3.84B | 3.74B | 3.5B | 3.37B | 3.33B | 3.3B | 3.08B | 2.98B |
| Fixed Asset Turnover | 1.14x | 1.20x | 1.23x | 1.30x | 1.23x | 1.26x | 1.23x | 1.23x | 1.16x | 1.17x | 1.16x | 1.23x |
| Goodwill | 18.54B | 18.28B | 18.21B | 18.08B | 17.34B | 17.09B | 15.03B | 14.4B | 14.36B | 14.39B | 13.61B | 13.66B |
| Intangible Assets | 7.06B | 7.02B | 7.16B | 7.26B | 6.57B | 6.68B | 5.75B | 5.42B | 5.84B | 6B | 5.85B | 6.06B |
| Long-Term Investments | 935M | 842M | 792M | 626M | 655M | 555M | 532M | 589M | 429M | 413M | 427M | 421M |
| Other Non-Current Assets | 573M | 559M | 546M | 746M | 732M | 749M | 684M | 546M | 737M | 679M | 732M | 728M |
| Total Assets | 44.35B | 43.67B | 42.71B | 41.56B | 40.14B | 39.4B | 38.08B | 37.11B | 36.67B | 35.14B | 34.04B | 33.6B |
| Asset Turnover | 0.12x | 0.12x | 0.12x | 0.12x | 0.12x | 0.12x | 0.11x | 0.11x | 0.11x | 0.11x | 0.10x | 0.11x |
| Asset Growth % | 10.49% | 10.86% | 12.16% | 11.99% | 9.47% | 12.12% | 11.85% | 10.44% | 11.48% | 8.21% | 6.56% | 4.38% |
| Total Current Liabilities | 4.57B | 5.44B | 5.33B | 5.19B | 5.06B | 6.4B | 5.91B | 5.58B | 4.92B | 4.93B | 4.58B | 4.56B |
| Accounts Payable | 1.14B | 1.14B | 1B | 962M | 1B | 960M | 907M | 906M | 921M | 942M | 929M | 899M |
| Days Payables Outstanding | 64.67 | 73.23 | 59.32 | 54.64 | 51.59 | 45.44 | 53.43 | 54.16 | 57.59 | 60.91 | 61.83 | 60.77 |
| Short-Term Debt | 41M | 389M | 483M | 480M | 777M | 1.78B | 1.65B | 1.58B | 1.08B | 531M | 513M | 559M |
| Deferred Revenue (Current) | 0 | 313M | 309M | 313M | 306M | 306M | 290M | 284M | 280M | 266M | 246M | 242M |
| Other Current Liabilities | 3.39B | 2.17B | 531M | 597M | 439M | 491M | 1.66B | 1.63B | 1.62B | 1.92B | 1.63B | 1.62B |
| Current Ratio | 1.90x | 1.62x | 1.51x | 1.37x | 1.45x | 1.08x | 1.48x | 1.61x | 1.66x | 1.32x | 1.42x | 1.29x |
| Quick Ratio | 1.22x | 1.08x | 0.96x | 0.82x | 0.88x | 0.64x | 1.02x | 1.14x | 1.14x | 0.82x | 0.90x | 0.80x |
| Cash Conversion Cycle | 158.35 | 176.98 | 166.57 | 154.08 | 148.21 | 140.98 | 158.12 | 151.01 | 151.83 | 151.68 | 150.82 | 140.34 |
| Total Non-Current Liabilities | 13.68B | 13.76B | 13.75B | 13.72B | 12.64B | 10.99B | 11.21B | 10.92B | 11.59B | 10.67B | 10.34B | 10.55B |
| Long-Term Debt | 10.86B | 11.46B | 10.99B | 10.98B | 10.41B | 8.84B | 9.23B | 8.99B | 9.53B | 8.57B | 8.38B | 8.49B |
| Capital Lease Obligations | 124M | 571M | 570M | 566M | 525M | 527M | 377M | 369M | 386M | 395M | 404M | 406M |
| Deferred Tax Liabilities | 219M | 220M | 242M | 226M | 158M | 155M | 138M | 132M | 132M | 134M | 91M | 135M |
| Other Non-Current Liabilities | 2.47B | 1.14B | 1.58B | 1.59B | 1.21B | 1.14B | 1.14B | 1.12B | 1.22B | 1.27B | 1.16B | 1.23B |
| Total Liabilities | 18.25B | 19.2B | 19.08B | 18.91B | 17.69B | 17.39B | 17.12B | 16.5B | 16.5B | 15.61B | 14.91B | 15.12B |
| Total Debt | 11.03B | 12.42B | 12.05B | 12.03B | 11.71B | 11.15B | 11.26B | 10.94B | 11B | 9.49B | 9.3B | 9.45B |
| Net Debt | 9.51B | 10.37B | 10.77B | 11.49B | 10.98B | 10.73B | 8.76B | 8.02B | 8.67B | 8.63B | 8.35B | 9.03B |
| Debt / Equity | 0.42x | 0.51x | 0.51x | 0.53x | 0.52x | 0.51x | 0.54x | 0.53x | 0.55x | 0.49x | 0.49x | 0.51x |
| Debt / EBITDA | 7.75x | 7.90x | 8.65x | 10.41x | 9.59x | 11.90x | 11.48x | 10.34x | 11.60x | 10.90x | 10.83x | 11.14x |
| Net Debt / EBITDA | 6.68x | 6.60x | 7.74x | 9.95x | 9.00x | 11.45x | 8.93x | 7.58x | 9.15x | 9.90x | 9.72x | 10.63x |
| Interest Coverage | 13.91x | 10.62x | 11.79x | 11.47x | 10.25x | 5.20x | 9.05x | 6.19x | 9.44x | 8.54x | 10.07x | 7.00x |
| Total Equity | 26.1B | 24.47B | 23.63B | 22.65B | 22.45B | 22B | 20.96B | 20.61B | 20.17B | 19.53B | 19.13B | 18.48B |
| Equity Growth % | 16.3% | 11.22% | 12.76% | 9.92% | 11.3% | 12.67% | 9.56% | 11.49% | 11.36% | 11.12% | 8.43% | 7.15% |
| Book Value per Share | 17.46 | 16.36 | 15.80 | 15.17 | 15.03 | 14.77 | 14.09 | 13.89 | 13.61 | 13.22 | 12.97 | 12.69 |
| Total Shareholders' Equity | 25.86B | 24.23B | 23.39B | 22.42B | 22.21B | 21.77B | 20.71B | 20.37B | 19.93B | 19.28B | 18.89B | 18.23B |
| Common Stock | 17M | 17M | 17M | 17M | 17M | 17M | 17M | 17M | 17M | 17M | 17M | 17M |
| Retained Earnings | 6.91B | 5.57B | 4.9B | 4.14B | 3.35B | 2.67B | 2.11B | 1.64B | 1.31B | 819M | 315M | -189M |
| Treasury Stock | -2.25B | -2.25B | -2.25B | -2.25B | -2.25B | -2.25B | -2.25B | -2.25B | -2.25B | -2.25B | -2.25B | -2.25B |
| Accumulated OCI | -398M | -610M | -689M | -722M | -28M | 275M | -128M | 164M | 133M | 49M | 231M | 208M |
| Minority Interest | 240M | 239M | 236M | 235M | 233M | 233M | 248M | 238M | 242M | 248M | 243M | 259M |